New Canaan s Fourth of July celebration postponed to July 11 ncadvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncadvertiser.com Daily Mail and Mail on Sunday newspapers.
Share:
Dr. John Kovach, the CEO and founder of Lixte Biotechnology Holdings, Inc., expressed excitement for his company’s first-in-class protein phosphatase inhibitor, LB-100 as a new addition to cancer treatment at the Benzinga Global Small Cap Business Conference on May 13, 2021.
Lixte Biotechnology (NASDAQ: LIXT), a drug discovery company, created and patented a series of novel drugs that enhance the effectiveness of standard anti-cancer therapy in a number of animal models.
More than 40 preclinical studies report that Lixte’s LB-100 increases the anti-tumor activity of standard chemotherapy, radiotherapy and immunotherapy without increasing toxicity.
Dr. Kovach noted that Lixte’s extensive international patent portfolio includes patents for LB-100 and its potential clinical applications based on lead compounds and some other drivers of those compounds. “We’re not aware of any competition at the moment, but we expect we’ll be getting some soon,” he said, “but w
Reply
The Young Marines, a national youth organization, announced the National Young Marine of the Year - YM/SgtMaj Mario Koch, 17, of North Olmsted, Ohio. He is a member of the Greater Cleveland Young Marines from Fairview Park, Ohio. Koch is a junior at North Olmsted High School.
Koch is the top Young Marine in the United States. Over the course of the year, he will travel to other units throughout the country to lead, motivate, and serve as a role model for other Young Marines.
As National Young Marine of the Year, Koch will escort WWII veterans to the annual Reunion of Honor trip to Guam and Iwo Jima in the fall of 2021.